Patents Assigned to SHANGHAI FO ZE MEDICAL TECHNOLOGY CO., LTD
  • Publication number: 20220315507
    Abstract: The present invention discloses a prostate specific membrane antigen (PSMA) binding compound, a radioactive isotope complex thereof, and the use thereof in nuclear medicine as a tracer and an imaging agent for different disease states of prostate cancer.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 6, 2022
    Applicant: SHANGHAI FO ZE MEDICAL TECHNOLOGY CO., LTD
    Inventors: SHAOLI SONG, XIAOPING XU, CHANG LIU